Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients - Scorecard - MDSpire

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • By

  • Makoto Hibino

  • Ayumi Shintani

  • Hiroyuki Murayama

  • Nobuyuki Morikawa

  • Kazunari Maeda

  • Sho Nishiguchi

  • Eiji Monma

  • Hiromasa Harada

  • Tsunekazu Takagi

  • Satoshi Kuroyanagi

  • Kiyoshi Endo

  • Yasushi Terada

  • Masahiro Kinoshita

  • Takahiro Yoden

  • Shogo Miyazawa

  • Shinichi Higashiue

  • May 15, 2026

  • 0 min

Share

Clinical Scorecard: Impact of Early Oral Antiviral Administration on Post–COVID-19 Syndrome in Outpatient Settings

At a Glance

CategoryDetail
Condition
Key MechanismsViral persistence, dysregulated immune responses, chronic inflammation, and specific symptoms like fatigue and respiratory issues.
Target Population
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • s
      • s
      • e
      • s
      • s
      • s
      • y
      • m
      • p
      • t
      • o
      • m
      • s
      • a
      • t
      • d
      • a
      • y
      • s
      • 2
      • 8
      • a
      • n
      • d
      • 8
      • 4
      • p
      • o
      • s
      • t
      • -
      • e
      • n
      • r
      • o
      • l
      • l
      • m
      • e
      • n
      • t
      • ,
      • f
      • o
      • c
      • u
      • s
      • i
      • n
      • g
      • o
      • n
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • p
      • e
      • r
      • s
      • i
      • s
      • t
      • e
      • n
      • t
      • s
      • y
      • m
      • p
      • t
      • o
      • m
      • s
      • .

      Risks

        Patient & Prescribing Data

        Clarify the rationale for ensitrelvir's use in all patients, regardless of risk factors.

        Clinical Best Practices

        • best_practice_2

        Related Resources & Content

        Original Source(s)

        Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

        • by Makoto Hibino, Ayumi Shintani, Hiroyuki Murayama, Nobuyuki Morikawa, Kazunari Maeda, Sho Nishiguchi, Eiji Monma, Hiromasa Harada, Tsunekazu Takagi, Satoshi Kuroyanagi, Kiyoshi Endo, Yasushi Terada, Masahiro Kinoshita, Takahiro Yoden, Shogo Miyazawa, Shinichi Higashiue

        • May 15, 2026

        Related Content

        Multi-omics analysis of long COVID (post-COVID-19 condition) reveals persistent mitochondrial dysfunction, suppressed oxidative phosphorylation, and immune dysregulation

        Top 10 States With Rising Demand for Physicians

        These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

        Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study